The Latest Cardiac and Vascular News
NEW YORK, Dec. 17, 2019 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq: MESO; ASX: MSB) today announced that its Phase 3 trial of Revascor for advanced chronic heart failure has surpassed the number of primary endpoint events required for trial completion. This cardiovascular outcomes trial has now initiated final study visits […]
Company Ramps Up Commercialization of ControlRad Trace, an FDA-cleared Technology to Reduce Radiation Exposure During Fluoroscopically Guided Procedures ATLANTA–(BUSINESS WIRE)–ControlRad, Inc., a privately held medical technology company focused on dramatically reducing unnecessary radiation exposure during fluoroscopically guided procedures (FGP), today announced several additions to its leadership team. Joining are Peter […]
FOUNTAIN VALLEY, CA – MemorialCare Orange Coast Medical Center has announced that it is now offering a new procedure called TransCarotid Artery Revascularization (TCAR) to treat carotid artery disease and prevent future strokes. TCAR is a clinically proven, minimally invasive and safe approach for high surgical risk patients who need […]
Dr. Michael Lichtenberg Treats First Patient in Arnsberg, Germany ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that the first patient in Europe has been treated with its […]
Novoheart engineered the world’s first “human heart-in-a-jar” as part of its proprietary MyHeart™ platform Novoheart receives exclusive license from Harvard University to integrate pioneering bioreactor technology that accommodates model ventricles and optional valves into the “human heart-in-a-jar” model The resultant next-generation model will have unparalleled biofidelity as well as enhanced […]
ST. LOUIS, Dec. 16, 2019 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announced today that HCA Midwest Health—the largest healthcare system in the Kansas City region—has launched a new robotic arrhythmia care program based at Overland Park Regional Medical Center […]
HOUSTON, Dec. 16, 2019 /PRNewswire/ — Millar, Inc., a leading manufacturer and OEM solutions provider of sensor-based devices for clinical and life science applications, is pleased to celebrate an ongoing and successful strategic worldwide partnership with ADInstruments, an industry leader of data acquisition systems. The exclusive worldwide distribution agreement originated in November 2014 with an official announcement at […]
Rouen, France, December 16, 2019 – Robocath, a company that designs, develops and commercializes cardiovascular robotic systems for the treatment of vascular diseases, today announces it has successfully completed six robotic coronary angioplasties with R-One™, a first for the continent of Africa. These Percutaneous Coronary Interventions (PCI) were performed by Dr Faizel […]
BOSTON–(BUSINESS WIRE)–A pivotal, multi-center clinical trial to explore a promising new therapy to reduce heart failure rates by changing the way heart attack patients are treated is now underway. The first patient has enrolled in the ST-Elevation Myocardial Infarction Door-to-Unloading (STEMI DTU) Pivotal Randomized Controlled Trial. The first enrollment took […]
DANVERS, Mass.–(BUSINESS WIRE)–Abiomed (NASDAQ: ABMD) announces initiation of the ST-Elevation Myocardial Infarction Door-to-Unloading (STEMI DTU) Pivotal Randomized Controlled Trial (RCT), which will explore whether unloading the heart’s left ventricle for 30 minutes with an Impella heart pump prior to opening blocked arteries will reduce infarct size after a heart attack and lead to […]
